Abstract:Secondary metabolites are organic compounds with complex chemical structures and diverse physiological functions. Secondary metabolites include antibiotics, pigments, and other bioactive compounds. Many of these compounds have important agricultural and medical applications. Microorganisms, especially actinomycetes and filamentous fungi, are noted as a rich source of bioactive secondary metabolites. Typically, each species produces several antibiotics, with the profile being species-specific. Secondary metabolites are synthesized from their precursors through multistep biosynthetic pathways. In general, the genes governing the biosynthesis of secondary metabolites are clustered together, and an increasing number of gene clusters responsible for the biosynthesis of secondary metabolites have been discovered. The availability of clusters has accelerated functional investigations of biosynthetic pathways of secondary metabolites. A thorough understanding of the enzymatic process is required for metabolic engineering to improve production of secondary metabolites and for combinatorial biosynthesis to generate novel compounds or derivatives. Elucidation of the biosynthetic process requires knowledge from diverse disciplines, including bioinformatics, chemistry, and genetics. Secondary metabolites are generally produced during the stationary phase of growth in microorganisms. The biosynthesis of secondary metabolites is a complex process involving cascade regulations, and these regulatory mechanisms have been investigated extensively at the transcriptional level. However, regulation could also occur at the pre-transcriptional and/or post-transcriptional levels. Pretranscriptional regulation occurs primarily at the chromatin level (epigenetic regulation), while post-transcriptional regulation is achieved via small non-coding RNAs (sRNAs) and protein degradation machinery. Though still in its infancy, some interesting progress has been made in this field [1,2]. As antibiotics are the most important of the secondary metabolites, we will focus on antibiotics hereafter. The alarming rise in emergence and prevalence of antibiotic resistance poses a major threat to human healthcare. It is clear that novel antibiotics are urgently needed to combat this problem. However, the supply of new antibiotics has declined in the last decade [3]. To reverse this trend, several strategies have been devised to find or create new antibiotics, which we describe in detail below.

Secondary metabolic pathway genes and new drug discovery

The Biosynthetic Gene Clusters of Aminocoumarin Antibiotics

Engineering fungal secondary metabolism: a roadmap to novel compounds.

Recent advances in awakening silent biosynthetic gene clusters and linking orphan clusters to natural products in microorganisms

Progress in strategies for cloning of antibiotics biosynthetic gene clusters

Genome Mining Reveals Novel Biosynthetic Gene Clusters in Entomopathogenic Bacteria

New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters

Tools of pathway reconstruction and production of economically relevant plant secondary metabolites in recombinant microorganisms

Biosynthesis and Regulation of Secondary Metabolites in Microorganisms

Combinatorial biosynthesis of novel aminoglycoside antibiotics via pathway engineering

Progress in functional genomics of drug-producing microorganisms

Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters

Computational Methods for Identification of Novel Secondary Metabolite Biosynthetic Pathways by Genome Analysis

Biosynthetic Pathways and Engineering for Bioactive Natural Products

Targeted Genome Mining—From Compound Discovery to Biosynthetic Pathway Elucidation

Synthetic biology-inspired strategies and tools for engineering of microbial natural product biosynthetic pathways

Genome mining of biosynthetic and chemotherapeutic gene clusters in Streptomyces bacteria

Unlocking the trove of metabolic treasures: activating silent biosynthetic gene clusters in bacteria and fungi

Synthetic Biology Tools for Novel Secondary Metabolite Discovery in Streptomyces

Current research status and vistas on metabolic engineering of nucleoside antibiotics